AIXPLORE
Live / Registered — Registered (as of 31 Mar 2026)
What this means for you
Registered since 31 Mar 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79426071
- Registration number
- 8190939
- Mark type
- Stylized text
- Filed
- 23 Jan 2025
- Published for opposition
- 10 Feb 2026
- Registered
- 31 Mar 2026
- Attorney of record
- Richard A. Castellano
Goods and services
- Class 009 — Scientific and electric apparatus: Downloadable or recorded computer software for conducting research in the fields of drug discovery, diagnostics, genetics, proteomics and identification, drug research, research and design of antibodies, proteins, peptides, biological products and chemicals, pharmaceutical research; downloadable or recorded computer software for use in antibody discovery and identification; downloadable or recorded artificial intelligence software for facilitating drug discovery, affinity maturation, engineering of biological products, studies of molecular interactions, humanization and identification, drug research, antibody research and design, pharmaceutical research; downloadable or recorded machine learning software for use in drug discovery and identification, drug research, antibody research and design, pharmaceutical research; downloadable software for conducting research and diagnostics in the field of genomics, proteomics, omics and developing biological products; downloadable or recorded big data generation software
- Class 042 — Scientific and technological services: Software as a service (SAAS) services featuring software for use in conducting research in the fields of drug discovery, diagnostics, genetics, proteomics and identification, drug research, antibody, protein, peptide, biological product and chemical product research and design, pharmaceutical research; medical research services in the field of medicine discovery; biological research; scientific analysis and research in the field of drug discovery, affinity maturation, biological product engineering, studies of molecular interactions, humanization and identification, drug research, antibody, protein, peptide, biological and chemical research and design, pharmaceutical research; antibody sequencing technology research; research and development services related to AI in the field of drug discovery and identification, drug research, antibody research and design, pharmaceutical research; research and development in the field of drug discovery and identification, drug research, research and design of antibodies, proteins, peptides, biological products and chemicals; research and development services in the field of antibody technology; electronic data storage and providing on-line non-downloadable software using artificial intelligence (AI) for machine learning
Owner
- ProteoGenix, FR
- ProteoGenix, FR
- ProteoGenix, FR
Prosecution history
- 06 Sept 2026 — FINAL DISPOSITION PROCESSED
- 30 Jun 2026 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 31 Mar 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 31 Mar 2026 — REGISTERED-PRINCIPAL REGISTER
- 10 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Feb 2026 — PUBLISHED FOR OPPOSITION
- 04 Feb 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 15 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 24 Nov 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 24 Nov 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 24 Nov 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 05 Sept 2025 — REFUSAL PROCESSED BY IB
- 17 Aug 2025 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 17 Aug 2025 — REFUSAL PROCESSED BY MPU
- 09 Jul 2025 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW